Senti Biosciences Holdings Inc (SNTI) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Senti Biosciences Holdings Inc   (NASDAQ: SNTI)


Senti Biosciences Holdings Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Senti Biosciences Holdings Inc 's ROA in the second quarter of 2026?
Senti Biosciences Holdings Inc recorded a cumulative net loss of $-50 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -109.19%.

However, within the Healthcare sector 760 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4252, from total ROA ranking in the first quarter of 2026 at 4936.

What is ROA?



Return On Assets (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Total Assets Change -42.48 % -53.8 % -39.91 % 20.83 % -4.26 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -50 -52 -61 -48 -58
Return On Assets (TTM) -109.19 % -97.86 % -96.29 % -65.8 % -83.27 %
SNTI's Total Ranking # 4252 # 4936 # 4158 # 4309 # 4330
Total Assets (TTM) in million 39 38 51 53 69
Seq. Total Assets Change 3.1 % -25.34 % -2.77 % -23.13 % -17.2 %
Seq. Net Income Change - - - - -



Return On Assets Company Ranking
Within: No.
Industry # 118
Sector # 761
Overall # 4266

Return On Assets Statistics
High Average Low
-2.22 %
-57.55 %
-113.12 %
(Dec 31 2021)   (Jun 30 2026)





Financial Statements
Senti Biosciences Holdings Inc 's Assets $ 39 million SNTI's Balance sheet
Senti Biosciences Holdings Inc 's Income $ -13 million Quarterly SNTI's Income Statement
SNTI's Income by Division See SNTI's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025
(Dec 31 2024)
FY 2024
(Dec 31 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
Y / Y Total Assets Change -39.91 % -56.77 % 21.19 % -29.7 % -
Total Assets in million 51 85 197 163 231
Y / Y Net Income Change - - - - -
Net Income in million -61 -53 -71 -58 -4
Annual Return On Assets -119.94 % -61.92 % -36.04 % -35.77 % -1.67 %




More Return On Assets Ratios
SNTI's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SNTI's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SNTI's Competitors
Subscribers only: Roa for Senti Biosciences Holdings Inc 's Suppliers
Subscribers only: Return On Assets for SNTI's Customers

You may also want to know
SNTI's Roi SNTI's Inventory Turnover Ratio SNTI's Growth Rates SNTI's Dividend Comparisons
SNTI's Profitability Ratios SNTI's Asset Turnover Ratio SNTI's Dividend Growth
SNTI's Roe SNTI's Valuation Ratios SNTI's Financial Strength Ratios SNTI's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA


Date modified: 2026-09-08T22:23:15+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.